Study of molecular and cellular mechanisms in mental disorders

• Grant number: 19/09207-3
• Support Opportunities: Scholarships in Brazil - Doctorate
• Start date: August 01, 2019
• End date: September 15, 2023
• Field of knowledge: Biological Sciences - Pharmacology - Biochemical and Molecular Pharmacology
• Principal Investigator: Mirian Akemi Furuie Hayashi
• Grantee: João Victor Silva Nani
• Host Institution: Instituto Nacional de Farmacologia (INFAR). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
• Associated research grant: 14/50891-1 - INCT 2014: Translational Medicine, AP.TEM
• Associated scholarship(s): 22/03297-3 - Exploring the molecular and cellular mechanism(s) underlying neurodevelopmental disorders: investigating the role(s) of Nuclear Distribution Element like-1 (Ndel1), BE.EP.DR

Abstract

Mental Disorders (MDs) are characterized by alterations in the functioning of the CNS, and these psychiatric conditions have attracted the attention of researchers from diverse areas due to the high prevalence and the highly debilitating clinical characteristics. Unlike most of the known organic diseases, the diagnosis for MDs still essentially based on clinical interviews, which can often lead to inaccurate diagnosis, as there are many similarities, especially in the symptoms, among the many well-known MDs. In order to better understand the biochemical and/or molecular changes involved in these pathologies, we are committed to demonstrate that oligopeptidases and the neuropeptidergic system play a key role both in the neurodevelopmental process and in the progression of these disorders. Although animal model studies for schizophrenia (SCZ) and clinical studies with SCZ patients have helped to better understand changes in oligopeptidase activity, it has not been possible to study the molecular and/or cellular pathways that may in fact indicate the mechanism(s) determining these disorders. Therefore, we propose in this work a biochemical, cellular and molecular evaluation, using different models with alterations already observed in the SCZ, before and after treatments with conventional antipsychotics and/or using innovative interventions, aiming to obtain more information about the molecular mechanism(s) involved in the MDs, and that can aid in the diagnosis, the discovery of new targets and the development of new therapies. (AU)

Scientific publications

(12)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

NANI, JOAO V.; LEE, RICHARD S.; YONAMINE, CAMILA M.; SANT'ANNA, OSVALDO A.; JULIANO, MARIA A.; GADELHA, ARY; MARI, JAIR J.; HAYASHI, MIRIAN A. F.. Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics. SCIENTIFIC REPORTS, v. 10, n. 1, OCT 28 2020. (19/09207-3, 17/02413-1, 12/50191-4, 13/13392-4)

CORREIA, BANNY SILVA BARBOSA; PONTES, JOAO GUILHERME DE MORAES; NANI, JOAO VICTOR SILVA; VILLALTA, FABIAN; MOR, NATALIA CRISTINA; BORDINI, DANIELA; BRUNONI, DECIO; BRENTANI, HELENA; MARI, JAIR JESUS; HAYASHI, MIRIAN A. F.; et al. 1H NMR Metabolomics and Lipidomics To Monitor Positive Responses in Children with Autism Spectrum Disorder Following a Guided Parental Intervention: A Pilot Study. ACS Chemical Neuroscience, v. 14, n. 6, p. 9-pg., 2023-02-21. (19/09207-3, 18/24069-3, 14/50867-3, 19/13112-8, 20/01107-7)

NANI, JOAO; GADELHA, ARY; HAYASHI, MIRIAN. Effect of Antipsychotics in the Angiotensin Converting Enzyme-1 (ACE) Activity in First-Episode Psychosis Patients and Animal Models for Schizophrenia. BIOLOGICAL PSYCHIATRY, v. 91, n. 9, p. 1-pg., 2022-05-01. (19/13112-8, 19/09207-3)

HAYASHI, MIRIAN A. F.; SALVETAT, NICOLAS; CAYZAC, CHRISTOPHER; CHECA-ROBLES, FRANCISCO JESUS; DUBUC, BENJAMIN; MEREUZE, SANDIE; V. NANI, JOAO; MOLINA, FRANCK; BRIETZKE, ELISA; WEISSMANN, DINAH. Euthymic and depressed bipolar patients are characterized by different RNA editing patterns in blood. PSYCHIATRY RESEARCH, v. 328, p. 4-pg., 2023-08-27. (19/08287-3, 22/03297-3, 19/09207-3, 19/13112-8, 20/01107-7, 22/00527-8, 17/02413-1, 14/50891-1)

SANTIAGO, THAYS CALISTA; PARRA, LARISSA; NANI, JOAO V.; FIDALGO, THIAGO M.; BRADSHAW, NICHOLAS J.; HAYASHI, MIRIAN A. F.. Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders. Journal of Neurochemistry, v. 166, n. 2, p. 18-pg., 2023-03-27. (19/08287-3, 22/03297-3, 19/09207-3, 19/13112-8, 20/01107-7, 22/00527-8, 17/02413-1, 14/50891-1)

ALTAF-UL-AMIN, MD.; HIROSE, KAZUHISA; NANI, JOAO V.; PORTA, LUCAS C.; TASIC, LJUBICA; HOSSAIN, SHAIKH FARHAD; HUANG, MING; ONO, NAOAKI; HAYASHI, MIRIAN A. F.; KANAYA, SHIGEHIKO. A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorder. SCIENTIFIC REPORTS, v. 11, n. 1, JUL 14 2021. (20/01107-7, 18/03102-2, 19/09207-3, 19/13112-8)

NANI, V, JOAO; FONSECA, MATHEUS C.; ENGI, SHEILA A.; PERILLO, MAYARA G.; DIAS, CARLOS S. B.; GAZARINI, MARCOS L.; KORTH, CARSTEN; CRUZ, FABIO C.; HAYASHI, MIRIAN A. F.. Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and amphetamine-supersensitivity. JOURNAL OF PSYCHOPHARMACOLOGY, v. 34, n. 4, JAN 2020. (14/50891-1, 18/20014-0, 17/02413-1, 19/09207-3)

NANI, V, JOAO; ALMEIDA, PRISCILA G. C.; NOTO, CRISTIANO; BRESSAN, RODRIGO A.; BRIETZKE, ELISA; HAYASHI, MIRIAN A. F.. Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia. NORDIC JOURNAL OF PSYCHIATRY, JAN 2022. (19/09207-3, 18/20014-0, 17/02413-1, 14/50891-1)

CAMPEIRO, JOANA D. `ARC; NANI, V, JOAP; MONTE, GABRIELA G.; ALMEIDA, PRISCILA G. C.; MORI, MARCELO A.; HAYASHI, MIRIAN A. F.. Regulation of monoamine levels by typical and atypical antipsychotics in Caenorhabditis elegans mutant for nuclear distribution element genes. NEUROCHEMISTRY INTERNATIONAL, v. 147, JUL 2021. (19/09207-3, 17/02413-1, 19/13112-8)

RODRIGUEZ, BENJAMIN; NANI, JOAO VICTOR; ALMEIDA, PRISCILA G. C.; BRIETZKE, ELISA; LEE, RICHARD S.; HAYASHI, MIRIAN A. F.. Neuropeptides and oligopeptidases in schizophrenia. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, v. 108, p. 679-693, JAN 2020. (14/50867-3, 14/50891-1, 17/02413-1, 14/18938-8, 19/09207-3)

NANI, V, JOAO; DAL MAS, CAROLINE; YONAMINE, CAMILA M.; OTA, VANESSA K.; NOTO, CRISTIANO; BELANGERO, I, SINTIA; MARI, JAIR J.; BRESSAN, RODRIGO; CORDEIRO, QUIRINO; GADELHA, ARY; et al. A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, v. 23, n. 11, p. 721-730, NOV 2020. (17/25016-8, 17/02413-1, 12/08941-6, 19/09207-3)

CORREIA, BANNY SILVA BARBOSA; NANI, JOAO VICTOR; WALADARES RICARDO, RANIERY; STANISIC, DANIJELA; COSTA, TASSIA BRENA BARROSO CARNEIRO; HAYASHI, MIRIAN A. F.; TASIC, LJUBICA. Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia. BIOMEDICINES, v. 9, n. 3, MAR 2021. (19/09207-3, 14/50867-3, 18/24069-3, 19/13112-8, 17/02413-1)